fig7

Targeting tumor-draining lymph node to overcome resistance to cancer immunotherapy: an update

Figure 7. Targeting TDLN to enhance T cell infiltration. (A) Targeting DCs in TDLN to prime and activate T cells; (B) Targeting macrophages in TDLN to regulate vascular and lymphatic homeostasis for T cell migration. Created in BioRender. Wang, L. (2025) https://BioRender.com/cg0mqy5. TDLN: Tumor-draining lymph node; DCs: dendritic cells; VEGF-C: vascular endothelial growth factor-C.